Jump to navigation

Home
  • About
    • About the Foundation
    • Video Library
    • Annual Report
    • Leadership
      • Research Advisory Board
      • Board of Directors
      • Executive Team
    • Staff
    • Organizational Reports
    • General FAQ
    • Contact Us
  • Research
    • Aging as We've Known It
      • The Path to a New Medicine
    • Introduction to SENS Research
      • Extracellular Junk
      • Intracellular Junk
      • Extracellular Crosslinks
      • Cell Loss and Atrophy
      • Death-Resistant Cells
      • Cancerous Cells
      • Mitochondrial Mutations
      • Delivery Systems
    • Grant Submission Process
    • Intramural
      • Mitochondrial Mutations
      • The ALT Mechanism
    • Extramural
      • Antibodies vs. Amyloids
      • Controlling Senescent Cell Effects
      • Enhancing Lipofuscin Clearance
      • Engineering a New Thymus
      • Quantifying Extracellular Crosslinks
      • Rejuvenating Risk/Benefit Analysis
      • Repopulating the Gut
      • Scaling Up Glucosepane Research
    • Past Projects
      • A Genetic Shortcut to Longevity?
      • Bacterial Enzymes for Human Eyes
      • Epimutations in Single Aging Cells
      • Finding Amyloid in the Heart
      • Lysosomes in Macular Degeneration
      • Maximally Modifiable Mice
      • Nuclear Genes, Mitochondrial Proteins
      • Population Growth Without Aging
      • Rejuvenating the Immune System
      • Rejuvenating the Microenvironment
      • Social Effects of Longer Healthy Lives
    • Publications
    • Research Blog
  • Outreach
    • Rejuvenation Biotechnology Conference 2016
      • RB2016 EVENT HOME
      • Live Stream
      • Event Program & Speakers
      • Hotel & Travel Information
      • Sponsorship & Exhibition
      • Sponsors
      • Media
    • RB2016 Conference Videos
    • RB2015 Conference Videos
    • RB2014 Conference Videos
    • Video Library
    • Events Calendar
    • Take Action
      • Student
      • Researcher
      • Mentor
      • Volunteer
    • Press Releases
    • SRF in the News
    • Celebrity Reimagine Aging Campaign
    • Conferences
      • Rejuvenation Biotechnology
      • SENS Conferences
      • Other Events
      • Abstract Archive
    • Outreach Blog
    • Newsletter Archive
  • Education
    • About SRF Education
      • SRF Education FAQ
    • Research Opportunities
      • SRF Summer Scholars Program
      • SRF-Oxford-CTSCC Research Program
      • Recent SRF Education Publications
    • SRF Education Videos
    • Education Blog
    • Contact SRF Education
  • Subscribe
  • DONATE

Search form

 
Download our Annual Report
Explore our Video Library

Silicon Valley vs. Death

Thumbnail

Tad Friend of The New Yorker presents a wide-ranging review of the various initiatives currently under way to extend healthy human lifespans - discussing the work of SENS Research Foundation, Google's Calico, Unity Biotechnology, and many others.

Read Article

LysoSENS to Enter Human Trials

Thumbnail
Ichor Therapeutics is seeking Series A funding for Phase I trials of LYSOCLEAR: the first potential cure for the more than 20 million Americans suffering from AMD (the leading cause of vision loss in those over 50), and the first clinical candidate based on the SENS paradigm.
Read Release

SRF and the Buck take on Tau

Thumbnail

We're proud to announce a new collaboration with the Buck Institute for Research on Aging's Dr. Julie Andersen, a leading expert on neurodegeneration. The project will focus on clearing tangles of tau protein - a key driver of Alzheimer's and similar diseases.

Press Release

Rejuvenating the Mitochondria

Thumbnail

As part of Google's Giving Week, MitoSENS project leader Dr. Matthew O'Connor gave a Tech Talk on December 9th introducing SRF and our "damage repair" approach to fighting aging - followed by an update on our progress in repairing defective mitochondria.

Watch Video

Aging Runs In The Blood

Thumbnail

Surgically connecting young and old mice reverses some aspects of aging, but isn't practical for humans! Fortunately for us, new SRF-funded work shows that transfusions of young blood produce many of the same benefits - paving the way towards human trials.

Free Paper in Nature Communications

February Newsletter

Thumbnail

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

Newsletter

Faces of Cancer

Thumbnail

During our Control ALT, Delete Cancer fundraiser, we invited donors to send us a photo of a friend or loved one whose life has been affected by, or lost to, cancer. We've assembled those images into our Faces of Cancer wall.

Visit the Wall

More Progress in Senolytics

Thumbnail

Deleting senescent cells from mice delays many age-related diseases. A recent paper from the Unity Biotechnology team, who aim to start human trials in 12-18 months, now identifies atherosclerosis as another deadly condition which may be prevented by senolytic drugs.

Read More

Our 115-Year Shelf Life?

Thumbnail

A recent demographic analysis in Nature by Vijg et al. has attracted global attention after concluding that there is a "natural limit" of around 115 years to human lifespans - but has also been criticised for undue pessimism regarding future medical advances.

Read More

Funding a Cure for Aging

Thumbnail

Project|21's first patron, German internet entrepeneur Michael Greve, has formally announced a list of the research efforts that will be supported over the next year by the initial $1m tranche of his donation - as well as the startup companies receiving seed funds.

Learn More

SENS Animated

Thumbnail

SENS Research Foundation has commissioned a series of 8 animations, narrated by actor Edward James Olmos, to explain the concept of SENS and some of the therapies that we're developing to end age-related disease for good.

Watch Videos

Forever Healthy

Thumbnail

Michael Greve, the first donor to our Project|21 campaign, gave a presentation at RB2016 discussing how his life led to a passionate interest in the long-term maintenance of human health - and ultimately his decision to commit $10 million to our work.

Watch Video

Bulletproof Radio

Thumbnail

Entrepreneur and biohacker Dave Asprey recently interviewed our Chief Science Officer, Dr. Aubrey de Grey, for the health podcast Bulletproof Radio. Their in-depth conversation covers a broad range of topics related to our current work and future plans.

Listen Now

Ending Aging Audiobook

Thumbnail

Our general introduction to SENS research, Ending Aging, is now available in audiobook format. All profits will go to SENS Research Foundation. If Ending Aging is your first purchase as a new Audible member, we also get a $50 "bounty" - so please consider signing up!

View on Audible.com

Regeneration vs. Aging

Thumbnail

A new article in Genetic Engineering & Biotechnology News explores how applying regenerative medicine to the accumulated damage of aging is becoming an increasingly mainstream idea, crediting SRF CSO Aubrey de Grey as a pioneer in the field.

Read Article
  • contact us
  • jobs
  • press
  • privacy policy
  • terms of use
  • organizational reports / 990s
  • DONATE
© 2017 SENS Research Foundation. All rights reserved.